secwatch.observer — SEC 8-K summary
======================================

Issuer:     Olema Pharmaceuticals, Inc. (OLMA)
CIK:        0001750284
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0000950170-24-002741
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Olema makes investor presentation available for JP Morgan Conference; no financial details disclosed
--------------------------------------------------------------------------------

- Presentation furnished as Exhibit 99.1, dated January 8, 2024.
- No specific clinical, financial, or pipeline updates provided in the filed text.
- Presentation is for the JP Morgan Healthcare Conference in January 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1750284/000095017024002741/0000950170-24-002741-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1750284/000095017024002741/olma-20240108.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-002741

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer